Outset Medical, Inc. OM
Nasdaq · XNAS · stock · Electromedical & Electrotherapeutic Apparatus
Chart by TradingView
6/9
Piotroski F — financial health
-9.87
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $119.5M | -$81.7M | $46.8M | -$47.1M | $127.0M |
| 2024 | $113.7M | -$128.0M | $38.6M | -$117.2M | $26.8M |
| 2023 | $130.4M | -$172.8M | $29.0M | -$134.8M | $122.9M |
| 2022 | $115.4M | -$163.0M | $17.8M | -$154.1M | $246.0M |
| 2021 | $102.6M | -$131.9M | $7.6M | -$133.4M | $374.1M |
| 2020 | $49.9M | -$121.5M | -$13.0M | -$108.1M | $328.6M |
Why these scores methodology →
Piotroski F-score: 6/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -9.87 (distress)
- Working capital / assets 0.806
- Retained earnings / assets -4.429
- EBIT / assets -0.252
- Equity / liabilities 0.923
Source: SEC EDGAR filings · CIK 0001484612 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.